Concepedia

Kirk N. Campbell

KN

Statistics

Publications

37

Citations

3.4K

H-Index

26

Active since

2007

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

Harvard University

Columbia University Irving Medical Center

Massachusetts General Hospital

University of Miami

Kirk N. Campbell is an author at Icahn School of Medicine at Mount Sinai specializing in medicine, nephrology, and chronic kidney disease.

ORCID

Top concepts

Publications per year

2007–2025

37

Publications

37

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A

Christian Faul, Mary Donnelly, Sandra Merscher et al. · Nature Medicine · 2008 · 974 citations · Full text

, , +12

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 205 citations · Full text

Regulation of podocyte survival and endoplasmic reticulum stress by fatty acids

Jonas Sieber, Maja T. Lindenmeyer, Kapil Kampe et al. · American Journal of Physiology-Renal Physiology · 2010 · 197 citations · Full text

, , +22

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS

Howard Trachtman, Peter J. Nelson, Sharon G. Adler et al. · Journal of the American Society of Nephrology · 2018 · 181 citations · Full text

Inaxaplin for Proteinuric Kidney Disease in Persons with Two <i>APOL1</i> Variants

Ogo Egbuna, Brandon Zimmerman, George Manos et al. · New England Journal of Medicine · 2023 · 180 citations

1–5 of 37